These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33321203)

  • 1. A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.
    Chowdhury UF; Sharif Shohan MU; Hoque KI; Beg MA; Sharif Siam MK; Moni MA
    Genomics; 2021 Jan; 113(1 Pt 1):331-343. PubMed ID: 33321203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains.
    Madanagopal P; Muthukumar H; Thiruvengadam K
    Comput Biol Chem; 2022 Jun; 98():107687. PubMed ID: 35537364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing potential siRNA molecule for the nucleocapsid(N) gene silencing of different SARS-CoV-2 strains of Bangladesh: Computational approach.
    Bappy SS; Shibly AZ; Sultana S; Mohiuddin AKM; Kabir Y
    Comput Biol Chem; 2021 Jun; 92():107486. PubMed ID: 33984653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2.
    Shawan MMAK; Sharma AR; Bhattacharya M; Mallik B; Akhter F; Shakil MS; Hossain MM; Banik S; Lee SS; Hasan MA; Chakraborty C
    Infect Genet Evol; 2021 Sep; 93():104951. PubMed ID: 34089909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak.
    Das A; Khurshid S; Ferdausi A; Nipu ES; Das A; Ahmed FF
    Comput Biol Chem; 2021 Aug; 93():107533. PubMed ID: 34166886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific delivering of RNAi using Spike's aptamer-functionalized lipid nanoparticles for targeting SARS-CoV-2: A strong anti-Covid drug in a clinical case study.
    Saify Nabiabad H; Amini M; Demirdas S
    Chem Biol Drug Des; 2022 Feb; 99(2):233-246. PubMed ID: 34714580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Computational Approach for Designing and Validating Small Interfering RNA against SARS-CoV-2 Variants.
    Dhotre K; Dass D; Banerjee A; Nema V; Mukherjee A
    Curr Comput Aided Drug Des; 2024; 20(6):876-887. PubMed ID: 37622690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein.
    Pal A; Dobhal S; Dey KK; Sharma AK; Savani V; Negi VS
    Comput Biol Chem; 2021 Dec; 95():107594. PubMed ID: 34736125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
    Mishra D; Suri GS; Kaur G; Tiwari M
    J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger!
    Habtemariam S; Berindan-Neagoe I; Cismaru CA; Schaafsma D; Nabavi SF; Ghavami S; Banach M; Nabavi SM
    J Cell Mol Med; 2020 Sep; 24(17):10267-10269. PubMed ID: 32677763
    [No Abstract]   [Full Text] [Related]  

  • 12. Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach.
    Hossain MU; Bhattacharjee A; Emon MTH; Chowdhury ZM; Mosaib MG; Mourin M; Das KC; Keya CA; Salimullah M
    Gene; 2021 Mar; 771():145368. PubMed ID: 33346100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
    Askari N; Hadizadeh M; Rashidifar M
    Infect Genet Evol; 2022 Jan; 97():105195. PubMed ID: 34954105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
    Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
    Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting sgRNA N secondary structure as a way of inhibiting SARS-CoV-2 replication.
    Baliga-Gil A; Soszynska-Jozwiak M; Ruszkowska A; Szczesniak I; Kierzek R; Ciechanowska M; Trybus M; Jackowiak P; Peterson JM; Moss WN; Kierzek E
    Antiviral Res; 2024 Aug; 228():105946. PubMed ID: 38925369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ncRNA transcriptomics-based approach to design siRNA molecules against SARS-CoV-2 double membrane vesicle formation and accessory genes.
    Nawaz R; Arif MA; Ahmad Z; Ahad A; Shahid M; Hassan Z; Husnain A; Aslam A; Raza MS; Mehmood U; Idrees M
    BMC Infect Dis; 2023 Dec; 23(1):872. PubMed ID: 38087193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights.
    Kadam SB; Sukhramani GS; Bishnoi P; Pable AA; Barvkar VT
    J Basic Microbiol; 2021 Mar; 61(3):180-202. PubMed ID: 33460172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of SARS-CoV-2 nucleocapsid protein.
    Huang Y; Chen J; Chen S; Huang C; Li B; Li J; Jin Z; Zhang Q; Pan P; Du W; Liu L; Liu Z
    Front Cell Infect Microbiol; 2024; 14():1415885. PubMed ID: 38846351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.